Programmed Death-1 Receptor (PD-1) as a Potential Prognosis Biomarker for Ovarian Cancer Patients.

Pawlowska, Anna; Suszczyk, Dorota; Tarkowski, Rafal; Paduch, Roman; Kotarski, Jan; Wertel, Iwona

Pawlowska, Anna; Suszczyk, Dorota; Tarkowski, Rafal; Paduch, Roman; Kotarski, Jan; Wertel, Iwona.

Afiliação

Pawlowska A; Independent Laboratory of Cancer Diagnostics and Immunology, I Chair and Department of Oncological Gynaecology and Gynaecology, Medical University of Lublin, Lublin 20-081, Poland.
Suszczyk D; Independent Laboratory of Cancer Diagnostics and Immunology, I Chair and Department of Oncological Gynaecology and Gynaecology, Medical University of Lublin, Lublin 20-081, Poland.
Tarkowski R; I Chair and Department of Oncological Gynaecology and Gynaecology, Medical University of Lublin, Lublin 20-081, Poland.
Paduch R; Department of Virology and Immunology, Maria Curie-Sklodowska University, Lublin 20-033, Poland.
Kotarski J; I Chair and Department of Oncological Gynaecology and Gynaecology, Medical University of Lublin, Lublin 20-081, Poland.
Wertel I; Independent Laboratory of Cancer Diagnostics and Immunology, I Chair and Department of Oncological Gynaecology and Gynaecology, Medical University of Lublin, Lublin 20-081, Poland.

Cancer Manag Res ; 12: 9691-9709, 2020.

Article em En | MEDLINE | ID: mdl-33116828

Palavras-chave

PD-1/PD-L1; grading; immunotherapy; ovarian cancer; programmed cell death receptor 1; survival

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Manag Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google